The DOI matches its Crossref record; 261 of the 261 references it cites were found in a registry or an index.
The Current State of Peptide Drug Discovery: Back to the Future?
Abstract
Over the past decade, peptide drug discovery has experienced a revival of interest and scientific momentum, as the pharmaceutical industry has come to appreciate the role that peptide therapeutics can play in addressing unmet medical needs and how this class of compounds can be an excellent complement or even preferable alternative to small molecule and biological therapeutics. In this Perspective, we give a concise description of the recent progress in peptide drug discovery in a holistic manner, highlighting enabling technological advances affecting nearly every aspect of this field: from lead discovery, to synthesis and optimization, to peptide drug delivery. An emphasis is placed on describing research efforts to overcome the inherent weaknesses of peptide drugs, in particular their poor pharmacokinetic properties, and how these efforts have been critical to the discovery, design, and subsequent development of novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
Lau, J., Bloch, P., Schäffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L. B., McGuire, J., Steensgaard, D. B., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00726 · Cited by 1,105
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Peptoids: a modular approach to drug discovery.
Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., & Marlowe, C. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9367 · Cited by 953
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
The influence of lipophilicity in drug discovery and design
Arnott, J. A., & Planey, S. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.714363 · Cited by 868
Protein Chemical Synthesis by Ligation of Peptide Hydrazides
Fang, G., Li, Y., Shen, F., Huang, Y., Li, J., Lin, Y., Cui, H., & Liu, L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100996 · Cited by 810
Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress: Miniperspective
Walensky, L. D., & Bird, G. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011675 · Cited by 795
Click Chemistry in Complex Mixtures: Bioorthogonal Bioconjugation
McKay, C. S., & Finn, M. G. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.002 · Cited by 768
Advances in Fmoc solid‐phase peptide synthesis
Behrendt, R., White, P., & Offer, J. (2016) · Journal of Peptide Science · doi:10.1002/psc.2836 · Cited by 760
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Future directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
Heinis, C., Rutherford, T., Freund, S., & Winter, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.184 · Cited by 743
Membrane protein assembly into Nanodiscs
Bayburt, T. H., & Sligar, S. G. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.10.024 · Cited by 727
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
Protein synthesis by native chemical ligation: Expanded scope by using straightforward methodology
Hackeng, T. M., Griffin, J. H., & Dawson, P. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10068 · Cited by 675
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669
Chang, Y. S., Graves, B., Guerlavais, V., Tovar, C., Packman, K., To, K.-H., Olson, K. A., Kesavan, K., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 660
Mas-Moruno, C., Rechenmacher, F., & Kessler, H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728639 · Cited by 647
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Finan, B., Yang, B., Ottaway, N., Smiley, D. L., Ma, T., Clemmensen, C., Chabenne, J., Zhang, L., Habegger, K. M., Fischer, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3761 · Cited by 645
Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences
Coin, I., Beyermann, M., & Bienert, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.454 · Cited by 638
Insights into the Mechanism and Catalysis of the Native Chemical Ligation Reaction
Johnson, E. C. B., & Kent, S. B. H. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058344i · Cited by 629
Hashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., Kita, Y., Kawasumi, M., Kouyama, K., Doyu, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101133498 · Cited by 623
Site-selective protein-modification chemistry for basic biology and drug development
Krall, N., da Cruz, F. P., Boutureira, O., & Bernardes, G. J. L. (2016) · Nature Chemistry · doi:10.1038/nchem.2393 · Cited by 583
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
Doré, A. S., Robertson, N., Errey, J. C., Ng, I., Hollenstein, K., Tehan, B., Hurrell, E., Bennett, K., Congreve, M., Magnani, F., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.014 · Cited by 553
Peptidomimetics, a synthetic tool of drug discovery
Vagner, J., Qu, H., & Hruby, V. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.009 · Cited by 538
Chemical synthesis of proteins using peptide hydrazides as thioester surrogates
Zheng, J.-S., Tang, S., Qi, Y.-K., Wang, Z.-P., & Liu, L. (2013) · Nature Protocols · doi:10.1038/nprot.2013.152 · Cited by 537
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Functional Selectivity and Biased Receptor Signaling
Kenakin, T. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 505
Organometallic palladium reagents for cysteine bioconjugation
Vinogradova, E. V., Zhang, C., Spokoyny, A. M., Pentelute, B. L., & Buchwald, S. L. (2015) · Nature · doi:10.1038/nature15739 · Cited by 502
Emerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498
N‐Methylation of Peptides and Proteins: An Important Element for Modulating Biological Functions
Chatterjee, J., Rechenmacher, F., & Kessler, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201205674 · Cited by 494
Albumin as a versatile platform for drug half-life extension
Sleep, D., Cameron, J., & Evans, L. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.023 · Cited by 485
Expanding and Reprogramming the Genetic Code of Cells and Animals
Chin, J. W. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035737 · Cited by 476
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Schellenberger, V., Wang, C.-W., Geething, N. C., Spink, B. J., Campbell, A., To, W., Scholle, M. D., Yin, Y., Yao, Y., Bogin, O., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1588 · Cited by 462
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
Strohl, W. R. (2015) · BioDrugs · doi:10.1007/s40259-015-0133-6 · Cited by 461
Orally Absorbed Cyclic Peptides
Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00838 · Cited by 445
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442
Butelase 1 is an Asx-specific ligase enabling peptide macrocyclization and synthesis
Nguyen, G. K. T., Wang, S., Qiu, Y., Hemu, X., Lian, Y., & Tam, J. P. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1586 · Cited by 431
Milton, R. C. D., Milton, S. C. F., & Kent, S. B. H. (1992) · Science · doi:10.1126/science.1604320 · Cited by 425
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
du Vigneaud, V., Ressler, C., Swan, J. M., Roberts, C. W., & Katsoyannis, P. G. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01641a004 · Cited by 422
Copper‐Catalyzed Azide–Alkyne Click Chemistry for Bioconjugation
Presolski, S. I., Hong, V. P., & Finn, M. G. (2011) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch110148 · Cited by 416
Rezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., & Jacobson, M. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063076p · Cited by 416
Expert consensus document: A consensus on the medical treatment of acromegaly
Giustina, A., Chanson, P., Kleinberg, D., Bronstein, M. D., Clemmons, D. R., Klibanski, A., van der Lely, A. J., Strasburger, C. J., Lamberts, S. W., Ho, K. K. Y., et al. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.21 · Cited by 407
Handbook of Biologically Active Peptides
(2013) · Elsevier eBooks · doi:10.1016/c2010-0-66490-x · Cited by 403
Hill, M. D., Martin, R. H., Mikulis, D., Wong, J. H., Silver, F. L., terBrugge, K. G., Milot, G., Clark, W. M., MacDonald, R. L., Kelly, M. E., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70225-9 · Cited by 400
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S. F., Kalgutkar, A. S., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.664 · Cited by 386
Intestinal permeation enhancers for oral peptide delivery
Maher, S., Mrsny, R. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.005 · Cited by 381
Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
Wang, F., Wang, Y., Zhang, X., Zhang, W., Guo, S., & Jin, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.020 · Cited by 377
Identification of d -Peptide Ligands Through Mirror-Image Phage Display
Schumacher, T. N. M., Mayr, L. M., Minor, D. L., Milhollen, M. A., Burgess, M. W., & Kim, P. S. (1996) · Science · doi:10.1126/science.271.5257.1854 · Cited by 376
Immunogenicity of protein therapeutics: The key causes, consequences and challenges
Baker, M., Reynolds, H. M., Lumicisi, B., & Bryson, C. J. (2010) · Self/Nonself · doi:10.4161/self.1.4.13904 · Cited by 372
Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 370
Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
Diao, L., & Meibohm, B. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0079-0 · Cited by 369
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
Nasal route and drug delivery systems
Türker, S., Onur, E., & Ózer, Y. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000026823.82950.ff · Cited by 354
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
Bird, G. H., Madani, N., Perry, A. F., Princiotto, A. M., Supko, J. G., He, X., Gavathiotis, E., Sodroski, J. G., & Walensky, L. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002713107 · Cited by 347
Polymer–drug conjugates: Origins, progress to date and future directions
Kopeček, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.014 · Cited by 347
Phage display-derived human antibodies in clinical development and therapy
Frenzel, A., Schirrmann, T., & Hust, M. (2016) · mAbs · doi:10.1080/19420862.2016.1212149 · Cited by 346
Pseudo-Prolines as a Solubilizing, Structure-Disrupting Protection Technique in Peptide Synthesis
Wöhr, T., Wahl, F., Nefzi, A., Rohwedder, B., Sato, T., Sun, X., & Mutter, M. (1996) · Journal of the American Chemical Society · doi:10.1021/ja961509q · Cited by 345
Schlapschy, M., Binder, U., Borger, C., Theobald, I., Wachinger, K., Kisling, S., Haller, D., & Skerra, A. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt023 · Cited by 342
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Chirmule, N., Jawa, V., & Meibohm, B. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9340-y · Cited by 335
Microwave heating in solid-phase peptide synthesis
Pedersen, S. L., Tofteng, A. P., Malik, L., & Jensen, K. J. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15214a · Cited by 332
Ziconotide: a review of its pharmacology and use in the treatment of pain
McGivern, J. G. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2007.3.1.69 · Cited by 310
90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide
Bushnell, D. L., O'Dorisio, T. M., O'Dorisio, M. S., Menda, Y., Hicks, R. J., Van Cutsem, E., Baulieu, J.-L., Borson-Chazot, F., Anthony, L., Benson, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8585 · Cited by 306
Aguirre, T. A. S., Teijeiro-Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.004 · Cited by 299
π-Clamp-mediated cysteine conjugation
Zhang, C., Welborn, M., Zhu, T., Yang, N. J., Santos, M. S., Van Voorhis, T., & Pentelute, B. L. (2016) · Nature Chemistry · doi:10.1038/nchem.2413 · Cited by 295
Zaykov, A. N., Mayer, J. P., & DiMarchi, R. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.36 · Cited by 287
Discovery and characterization of smORF-encoded bioactive polypeptides
Saghatelian, A., & Couso, J. P. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1964 · Cited by 286
ChemMatrix, a Poly(ethylene glycol)-Based Support for the Solid-Phase Synthesis of Complex Peptides
García-Martín, F., Quintanar-Audelo, M., García-Ramos, Y., Cruz, L. J., Gravel, C., Furic, R., Côté, S., Tulla-Puche, J., & Albericio, F. (2006) · Journal of Combinatorial Chemistry · doi:10.1021/cc0600019 · Cited by 285
Burgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
Chen, H., Niu, G., Wu, H., & Chen, X. (2016) · Theranostics · doi:10.7150/thno.13242 · Cited by 282
Trends in clinical success rates
Smietana, K., Siatkowski, M., & Møller, M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.85 · Cited by 277
Site-specific N-terminal labeling of proteins using sortase-mediated reactions
Theile, C. S., Witte, M. D., Blom, A. E. M., Kundrat, L., Ploegh, H. L., & Guimaraes, C. P. (2013) · Nature Protocols · doi:10.1038/nprot.2013.102 · Cited by 273
Protein chemical synthesis by serine and threonine ligation
Zhang, Y., Xu, C., Lam, H. Y., Lee, C. L., & Li, X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221012110 · Cited by 272
Self‐assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers
Bayburt, T. H., & Sligar, S. G. (2003) · Protein Science · doi:10.1110/ps.03267503 · Cited by 270
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Jawa, V., Cousens, L. P., Awwad, M., Wakshull, E., Kropshofer, H., & De Groot, A. S. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.09.006 · Cited by 270
Protein conjugation with genetically encoded unnatural amino acids
Kim, C. H., Axup, J. Y., & Schultz, P. G. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.017 · Cited by 269
Reissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
Development of α-Helical Calpain Probes by Mimicking a Natural Protein–Protein Interaction
Jo, H., Meinhardt, N., Wu, Y., Kulkarni, S., Hu, X., Low, K. E., Davies, P. L., DeGrado, W. F., & Greenbaum, D. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307599z · Cited by 261
Insulin analogues in type 1 diabetes mellitus: Getting better all the time
Mathieu, C., Gillard, P., & Benhalima, K. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.39 · Cited by 248
Peptidomimetics – A Versatile Route to Biologically Active Compounds
Grauer, A., & König, B. (2009) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200900599 · Cited by 247
Wang, J., Yadav, V., Smart, A. L., Tajiri, S., & Basit, A. W. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500809f · Cited by 245
Nasal Delivery of High Molecular Weight Drugs
Ozsoy, Y., Gungor, S., & Cevher, E. (2009) · Molecules · doi:10.3390/molecules14093754 · Cited by 242
In Vitro Selection of Highly Modified Cyclic Peptides That Act as Tight Binding Inhibitors
Guillen Schlippe, Y. V., Hartman, M. C. T., Josephson, K., & Szostak, J. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301017y · Cited by 239
The road to the synthesis of “difficult peptides”
Paradís-Bas, M., Tulla-Puche, J., & Albericio, F. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00680e · Cited by 235
Ribosomal Synthesis of Unnatural Peptides
Josephson, K., Hartman, M. C. T., & Szostak, J. W. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0515809 · Cited by 233
Wong, C. T. T., Rowlands, D. K., Wong, C., Lo, T. W. C., Nguyen, G. K. T., Li, H., & Tam, J. P. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201200984 · Cited by 229
From snake venom toxins to therapeutics – Cardiovascular examples
Koh, C. Y., & Kini, R. M. (2012) · Toxicon · doi:10.1016/j.toxicon.2011.03.017 · Cited by 228
Selection-Based Discovery of Druglike Macrocyclic Peptides
Passioura, T., Katoh, T., Goto, Y., & Suga, H. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035456 · Cited by 222
Application of Combinatorial Chemistry Science on Modern Drug Discovery
Kennedy, J. P., Williams, L., Bridges, T. M., Daniels, R. N., Weaver, D., & Lindsley, C. W. (2008) · Journal of Combinatorial Chemistry · doi:10.1021/cc700187t · Cited by 213
mRNA display: from basic principles to macrocycle drug discovery
Josephson, K., Ricardo, A., & Szostak, J. W. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.011 · Cited by 210
Leuprolide acetate: a drug of diverse clinical applications
Wilson, A. C., Vadakkadath Meethal, S., Bowen, R. L., & Atwood, C. S. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1851 · Cited by 207
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., & Luttrell, L. M. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000071 · Cited by 205
Antigenicity and Immunogenicity of Synthetic Peptides
Van Regenmortel, M. H. V. (2001) · Biologicals · doi:10.1006/biol.2001.0308 · Cited by 204
Microneedles for Drug Delivery via the Gastrointestinal Tract
Traverso, G., Schoellhammer, C. M., Schroeder, A., Maa, R., Lauwers, G. Y., Polat, B. E., Anderson, D. G., Blankschtein, D., & Langer, R. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24182 · Cited by 202
Malyshev, D. A., & Romesberg, F. E. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502890 · Cited by 200
Matthews, J. E., Stewart, M. W., De Boever, E. H., Dobbins, R. L., Hodge, R. J., Walker, S. E., Holland, M. C., Bush, M. A., & for the Albiglutide Study Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1518 · Cited by 198
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
Luttrell, L. M., Maudsley, S., & Bohn, L. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099630 · Cited by 190
Komin, A., Russell, L. M., Hristova, K. A., & Searson, P. C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.002 · Cited by 189
Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets
Tang, X.-L., Wang, Y., Li, D.-L., Luo, J., & Liu, M.-Y. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.210 · Cited by 188
Insights into the chemical logic and enzymatic machinery of NRPS assembly lines
Walsh, C. T. (2016) · Natural Product Reports · doi:10.1039/c5np00035a · Cited by 181
Ahlbach, C. L., Lexa, K. W., Bockus, A. T., Chen, V., Crews, P., Jacobson, M. P., & Lokey, R. S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.78 · Cited by 178
Peptides As Therapeutics with Enhanced Bioactivity
Goodwin, D., Simerska, P., & Toth, I. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803251548 · Cited by 176
Peptides and Proteins as a Continuing Exciting Source of Inspiration for Peptidomimetics
Liskamp, R. M. J., Rijkers, D. T. S., Kruijtzer, J. A. W., & Kemmink, J. (2011) · ChemBioChem · doi:10.1002/cbic.201000717 · Cited by 175
Wang, C. K., Northfield, S. E., Colless, B., Chaousis, S., Hamernig, I., Lohman, R.-J., Nielsen, D. S., Schroeder, C. I., Liras, S., Price, D. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417611111 · Cited by 171
Manufacturing Peptides as Active Pharmaceutical Ingredients
Zompra, A. A., Galanis, A. S., Werbitzky, O., & Albericio, F. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.23 · Cited by 170
Prospective identification of parasitic sequences in phage display screens
Matochko, W. L., Li, S. C., Tang, S. K. Y., & Derda, R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1104 · Cited by 170
The artificial pancreas: current status and future prospects in the management of diabetes
Peyser, T., Dassau, E., Breton, M., & Skyler, J. S. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12431 · Cited by 169
Biased Ligands for Better Cardiovascular Drugs: Dissecting G-Protein-Coupled Receptor Pharmacology
DeWire, S. M., & Violin, J. D. (2011) · Circulation Research · doi:10.1161/circresaha.110.231308 · Cited by 167
Recent advances in sortase-catalyzed ligation methodology
Antos, J. M., Truttmann, M. C., & Ploegh, H. L. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.05.021 · Cited by 166
Immunogenicity of therapeutic proteins: the use of animal models
Brinks, V., Jiskoot, W., & Schellekens, H. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0523-5 · Cited by 164
Dinca, A., Chien, W.-M., & Chin, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020263 · Cited by 164
Working outside the protein‐synthesis rules: insights into non‐ribosomal peptide synthesis
Marahiel, M. A. (2009) · Journal of Peptide Science · doi:10.1002/psc.1183 · Cited by 163
Werner, H. M., Cabalteja, C. C., & Horne, W. S. (2016) · ChemBioChem · doi:10.1002/cbic.201500312 · Cited by 160
Taylor, M., Moore, S., Mayes, J., Parkin, E., Beeg, M., Canovi, M., Gobbi, M., Mann, D. M. A., & Allsop, D. (2010) · Biochemistry · doi:10.1021/bi100144m · Cited by 160
O’Callaghan, K., Kuliopulos, A., & Covic, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.355461 · Cited by 159
Black, C., Cummins, E., Royle, P., Philip, S., & Waugh, N. R. (2007) · Health Technology Assessment · doi:10.3310/hta11330 · Cited by 159
Discussion about Several Potential Drawbacks of PEGylated Therapeutic Proteins
Zhang, F., Liu, M.-R., & Wan, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00661 · Cited by 157
Safety concerns over the use of intestinal permeation enhancers: A mini-review
McCartney, F., Gleeson, J. P., & Brayden, D. J. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1176822 · Cited by 156
Stapling peptides using cysteine crosslinking
Fairlie, D. P., & de Araujo, A. D. (2016) · Biopolymers · doi:10.1002/bip.22877 · Cited by 155
To protect peptide pharmaceuticals against peptidases
Rink, R., Arkema-Meter, A., Baudoin, I., Post, E., Kuipers, A., Nelemans, S. A., Akanbi, M. H. J., & Moll, G. N. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.02.010 · Cited by 153
Broqua, P., Rivière, P. J.-M., Conn, P. M., Rivier, J., Aubert, M. L., & Junien, J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.95 · Cited by 152
Kluskens, L., Nelemans, S. A., Rink, R., de Vries, L., Meter-Arkema, A. H., Wang, Y., Walther, T., Kuipers, A., Moll, G. N., & Haas, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146431 · Cited by 150
Discovery, structure, function, and applications of cyclotides: circular proteins from plants
Weidmann, J., & Craik, D. J. (2016) · Journal of Experimental Botany · doi:10.1093/jxb/erw210 · Cited by 147
Bioengineering Lantibiotics for Therapeutic Success
Field, D., Cotter, P. D., Hill, C., & Ross, R. P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01363 · Cited by 146
Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
Zhang, H., Sturchler, E., Zhu, J., Nieto, A., Cistrone, P. A., Xie, J., He, L., Yea, K., Jones, T. M., Turn, R. E., et al. (2015) · Nature Communications · doi:10.1038/ncomms9918 · Cited by 143
Cysteine‐Selective Reactions for Antibody Conjugation
Cal, P. M. S. D., Bernardes, G. J. L., & Góis, P. M. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405702 · Cited by 142
Current methods for the synthesis of homogeneous antibody–drug conjugates
Sochaj, A. M., Świderska, K. W., & Otlewski, J. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.001 · Cited by 142
Intein Applications: From Protein Purification and Labeling to Metabolic Control Methods
Wood, D. W., & Camarero, J. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.552653 · Cited by 139
Busby, R. W., Kessler, M. M., Bartolini, W. P., Bryant, A. P., Hannig, G., Higgins, C. S., Solinga, R. M., Tobin, J. V., WAKEFIELD, J. D., Kurtz, C. B., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.199430 · Cited by 139
Moskal, J. R., Burch, R. M., Burgdorf, J. S., Kroes, R. A., Stanton, P. K., Disterhoft, J. F., & Leander, J. D. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.852536 · Cited by 137
Peptide Ligands Stabilized by Small Molecules
Chen, S., Bertoldo, D., Angelini, A., Pojer, F., & Heinis, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309459 · Cited by 137
Recent extensions to native chemical ligation for the chemical synthesis of peptides and proteins
Malins, L. R., & Payne, R. J. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.09.021 · Cited by 136
Chemical generation of bispecific antibodies
Doppalapudi, V. R., Huang, J., Liu, D., Jin, P., Liu, B., Li, L., Desharnais, J., van Hagen, C., Levin, N. J., Shields, M. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016478108 · Cited by 131
Advances in phage display technology for drug discovery
Omidfar, K., & Daneshpour, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1037738 · Cited by 129
Zhou, X. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90071-x · Cited by 128
Retro-Inverso Isomer of Angiopep-2: A Stable d -Peptide Ligand Inspires Brain-Targeted Drug Delivery
Wei, X., Zhan, C., Chen, X., Hou, J., Xie, C., & Lu, W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500086e · Cited by 127
Fragment Screening of Stabilized G-Protein-Coupled Receptors Using Biophysical Methods
Congreve, M., Rich, R. L., Myszka, D. G., Figaroa, F., Siegal, G., & Marshall, F. H. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381274-2.00005-4 · Cited by 125
From somatostatin to octreotide LAR: evolution of a somatostatin analogue
Anthony, L. B., & Freda, P. U. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903328959 · Cited by 124
Encoded libraries of chemically modified peptides
Heinis, C., & Winter, G. P. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.02.008 · Cited by 124
Parkes, D. G., Mace, K. F., & TRAUTMANN, M. E. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.741580 · Cited by 123
Rosenstock, J., Balas, B., Charbonnel, B. H., Bolli, G. B., Boldrin, M. N., Ratner, R. E., Balena, R., & for the T-emerge 2 Study Group (2012) · Diabetes Care · doi:10.2337/dc12-0709 · Cited by 119
Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery
Gould, A., Ji, Y., Aboye, T. L., et al. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798999438 · Cited by 118
Predicting and Improving the Membrane Permeability of Peptidic Small Molecules
Rafi, S. B., Hearn, B. R., Vedantham, P., Jacobson, M. P., & Renslo, A. R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201634q · Cited by 117
Rohde, H., & Seitz, O. (2010) · Biopolymers · doi:10.1002/bip.21442 · Cited by 115
Allostery and biased agonism at class B G protein-coupled receptors
Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112
Jiang, G., Stalewski, J., Galyean, R., Dykert, J., Schteingart, C. D., Broqua, P., Aebi, A., Aubert, M. L., Semple, G., Robson, P. A., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0003900 · Cited by 109
The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus.
Ohuchi, M., Murakami, H., & Suga, H. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.011 · Cited by 109
An oxazetidine amino acid for chemical protein synthesis by rapid, serine-forming ligations
Pusterla, I., & Bode, J. W. (2015) · Nature Chemistry · doi:10.1038/nchem.2282 · Cited by 108
Amiram, M., Luginbuhl, K. M., Li, X., Feinglos, M. N., & Chilkoti, A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.021 · Cited by 108
Site‐Specific N‐Terminal Labeling of Peptides and Proteins using Butelase 1 and Thiodepsipeptide
Nguyen, G. K. T., Cao, Y., Wang, W., Liu, C., & Tam, J. P. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506810 · Cited by 105
Cleal, K., He, L., Watson, P., & Jones, A. T. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990297 · Cited by 101
Structuring Detergents for Extracting and Stabilizing Functional Membrane Proteins
Matar, R., Rhimi, M., Leydier, A., Huché, F., Galián, C., Mandon, E. D., Ficheux, D., Flot, D. M., Aghajari, N., Kahn, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018036 · Cited by 100
Identifying ligands at orphan GPCRs: current status using structure‐based approaches
Ngo, T., Kufareva, I., Coleman, J. L. J., Graham, R. M., Abagyan, R. A., & Smith, N. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13452 · Cited by 99
Peptide Scanning for Studying Structure‐Activity Relationships in Drug Discovery
Jamieson, A. G., Boutard, N., Sabatino, D. A., & Lubell, W. D. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12042 · Cited by 98
Ligation of Expressed Protein α-Hydrazides via Genetic Incorporation of an α-Hydroxy Acid
Li, Y., Yang, M., Huang, Y., Li, Y.-T., Chen, P. R., & Liu, L. (2012) · ACS Chemical Biology · doi:10.1021/cb300020s · Cited by 97
Engel, J. B., Emons, G., Pinski, J., & Schally, A. V. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.685128 · Cited by 96
Smith, A. J. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114562544 · Cited by 94
Peptidomics for the discovery and characterization of neuropeptides and hormones
Romanova, E. V., & Sweedler, J. V. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.05.009 · Cited by 92
Different roles of D‐amino acids in immune phenomena
Seia, M., & Zisman, E. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194525 · Cited by 90
Thwala, L. N., Véronique Préat, A., & Csaba, N. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1206074 · Cited by 90
Jimenez‐Solem, E., Rasmussen, M. H., Christensen, M., & Knop, F. K. (2010) · PubMed · Cited by 89
Benkirane-Jessel, N., Friede, M., Guichard, G., Briand, J., Regenmortel, M. H. V. V., & Muller, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74312-9 · Cited by 89
Wieland, T., & Bodanszky, M. (1991) · Springer eBooks · doi:10.1007/978-3-642-75850-8 · Cited by 89
Effect of α,α-Dialkyl Amino Acids on the Protease Resistance of Peptides
Yamaguchi, H., Kodama, H., Osada, S., Kato, F., Jelokhani‐Niaraki, M., & Kondo, M. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.2269 · Cited by 88
Zhang, P., Gruber, A., Kasuda, S., Kimmelstiel, C. D., O’Callaghan, K., Cox, D. H., Bohm, A., Baleja, J., Covic, L., & Kuliopulos, A. (2012) · Circulation · doi:10.1161/circulationaha.112.091918 · Cited by 88
Phage Selection of Chemically Stabilized α-Helical Peptide Ligands
Diderich, P., Bertoldo, D., Dessen, P., Maola, K. M. G., Pizzitola, I., Held, W., Huelsken, J., & Heinis, C. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00963 · Cited by 88
Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin
Heinemann, L., Baughman, R., Boss, A., & Hompesch, M. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816658055 · Cited by 88
Butelase‐Mediated Macrocyclization of d ‐Amino‐Acid‐Containing Peptides
Nguyen, G. K. T., Hemu, X., Quek, J. P., & Tam, J. P. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201607188 · Cited by 87
Synthesis and Biological Evaluation of an Orally Active Glycosylated Endomorphin-1
Varamini, P., Mansfeld, F. M., Blanchfield, J. T., Wyse, B. D., Smith, M. T., & Tóth, I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300418d · Cited by 83
Henry, R. R., Rosenstock, J., Logan, D. K., Alessi, T. R., Luskey, K. L., & Baron, M. A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.12.009 · Cited by 82
Khoury, E., Clément, S., & Laporte, S. A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00068 · Cited by 82
Sadowsky, J., Murray, J. K., Tomita, Y. A., & Gellman, S. H. (2007) · ChemBioChem · doi:10.1002/cbic.200600546 · Cited by 79
Acid-Mediated Prevention of Aspartimide Formation in Solid Phase Peptide Synthesis
Michels, T., Dölling, R., Haberkorn, U., & Mier, W. (2012) · Organic Letters · doi:10.1021/ol3007925 · Cited by 78
Amino acid composition of proteins reduces deleterious impact of mutations
Hormoz, S. (2013) · Scientific Reports · doi:10.1038/srep02919 · Cited by 77
Fidel, J. L., Kennedy, K. C., Dernell, W. S., Hansen, S. J., Wiss, V., Stroud, M. R., Molho, J. I., Knoblaugh, S. E., Meganck, J. A., Olson, J. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0471 · Cited by 77
In vivo phage display — A discovery tool in molecular biomedicine
Bábíčková, J., Tóthová, Ľ., Boor, P., & Celec, P. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.04.004 · Cited by 75
Moreau, J.-P., Delavault, P., & Blumberg, J. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.018 · Cited by 74
Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II
Oppedijk, S. F., Martin, N. I., & Breukink, E. J. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.024 · Cited by 73
Biosynthesis of therapeutic natural products using synthetic biology
Awan, A. R., Shaw, W. M., & Ellis, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.010 · Cited by 73
Identification and characterization of sORF-encoded polypeptides
Chu, Q., Ma, J., & Saghatelian, A. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1016215 · Cited by 72
Maybauer, M. O., Maybauer, D. M., Enkhbaatar, P., Laporte, R., Wiśniewska, H., Traber, L. D., Lin, C., Fan, J., Hawkins, H. K., Cox, R. A., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000300 · Cited by 72
Sohma, Y., & Kent, S. B. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9052398 · Cited by 71
Boll, E., Drobecq, H., Ollivier, N., Blanpain, A., Raibaut, L., Desmet, R., Vicogne, J., & Melnyk, O. (2015) · Nature Protocols · doi:10.1038/nprot.2015.013 · Cited by 71
Native Chemical Ligation: A Boon to Peptide Chemistry
Thapa, P., Zhang, R., Menon, V., & Bingham, J. (2014) · Molecules · doi:10.3390/molecules190914461 · Cited by 70
Cure and Curse: E. coli Heat-Stable Enterotoxin and Its Receptor Guanylyl Cyclase C
Weiglmeier, P. R., ROSCH, P. J., & Berkner, H. (2010) · Toxins · doi:10.3390/toxins2092213 · Cited by 70
Biodegradable Tetra-PEG Hydrogels as Carriers for a Releasable Drug Delivery System
Henise, J., Hearn, B. R., Ashley, G. W., & Santi, D. V. (2015) · Bioconjugate Chemistry · doi:10.1021/bc5005476 · Cited by 69
Mechanism of Action of the Arylomycin Antibiotics and Effects of Signal Peptidase I Inhibition
Smith, P. A., & Romesberg, F. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00785-12 · Cited by 69
Application of Dmb-Dipeptides in the Fmoc SPPS of Difficult and Aspartimide-Prone Sequences
Cardona, V. M. F., Eberle, I., Barthélémy, S., et al. (2008) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-008-9154-z · Cited by 68
Lessons learned from the clinical development of oral peptides
Karsdal, M. A., Riis, B. J., Mehta, N., Stern, W., Arbit, E., Christiansen, C., & Henriksen, K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12557 · Cited by 67
Cited by
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 654
Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production
Isidro-Llobet, A., Kenworthy, M. N., Mukherjee, S., Kopach, M. E., Wegner, K., Gallou, F., Smith, A. G., & Roschangar, F. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b03001 · Cited by 473
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Metadata
- Authors
- Henninot, A., Collins, J. C., & Nuss, J. M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-08-11
- Volume
- 61
- Issue
- 4
- Pages
- 1382-1414
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2739354616
- Cited by
- 1,113
- References
- 261
- FWCI
- 29.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.